(ALAI) The Alger Trust - Overview
Etf: Artificial Intelligence Equity, Non-Diversified, Growth, Market Capitalization
Dividends
| Dividend Yield | 1.51% |
| Yield on Cost 5y | 2.75% |
| Yield CAGR 5y | 212.72% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 31.7% |
| Relative Tail Risk | 5.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.75 |
| Alpha | 5.87 |
| Character TTM | |
|---|---|
| Beta | 1.431 |
| Beta Downside | 1.395 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.36% |
| CAGR/Max DD | 1.24 |
Description: ALAI The Alger Trust January 18, 2026
The Alger ETF Trust (NYSE ARCA: ALAI) is a U.S.-based, technology-focused ETF that commits at least 80% of its net assets (plus any borrowings) to equity securities of companies-regardless of market cap-that its manager expects to benefit materially from artificial-intelligence applications over the next 12-36 months. The fund is classified as “non-diversified,” meaning a single holding may exceed 35% of total assets, which amplifies both upside potential and concentration risk.
Key data points as of the latest filing: the fund’s expense ratio is 0.85%, and its assets under management (AUM) total roughly $120 million. The AI sector is projected by IDC to grow at a 20% CAGR through 2029, driven by enterprise AI spending (expected to reach $500 billion by 2027) and the rapid adoption of AI-optimized chips, which have seen a 45% YoY revenue increase in Q3 2024. These macro trends underpin the fund’s thesis that AI-enabled companies can deliver outsized earnings growth and stock price appreciation.
For a deeper, data-driven assessment of ALAI’s holdings and risk profile, you may find ValueRay’s analytical dashboards useful.
What is the price of ALAI shares?
Over the past week, the price has changed by -3.21%, over one month by -6.90%, over three months by -4.50% and over the past year by +25.41%.
Is ALAI a buy, sell or hold?
What are the forecasts/targets for the ALAI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 41.4 | 19.3% |
ALAI Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 294.5m USD (294.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 294.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 294.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 11.19% (E(294.5m)/V(294.5m) * Re(11.19%) + (debt-free company))
Discount Rate = 11.19% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)